105 related articles for article (PubMed ID: 7223173)
21. Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
Onsrud M
Gynecol Oncol; 1982 Dec; 14(3):355-64. PubMed ID: 6983994
[No Abstract] [Full Text] [Related]
22. [A case of total regression of endometrial carcinoma metastases in the lung under hormonal therapy (author's transl)].
Caminati M; Hauser GA
Ther Umsch; 1979 Jun; 36(6):516-7. PubMed ID: 462406
[No Abstract] [Full Text] [Related]
23. [Use of 19-nor-17 alpha-hydroxyprogesterone caproate in endometrial cancer].
Márquez J; Dabancens A; González O; Rosmanich A
Rev Chil Obstet Ginecol; 1976; 41(5):304-11. PubMed ID: 1030512
[No Abstract] [Full Text] [Related]
24. Endometrial carcinoma in Stein-Leventhal syndrome treated with hydroxyprogesterone caproate.
Eddy WA
Am J Obstet Gynecol; 1978 Jul; 131(5):581-2. PubMed ID: 677198
[No Abstract] [Full Text] [Related]
25. [Experiences with gestagens in the treatment of carcinoma of the uterus].
Buchheim CE
Schweiz Rundsch Med Prax; 1971 Jun; 60(23):763-70. PubMed ID: 5092313
[No Abstract] [Full Text] [Related]
26. [Steroid receptors in the gestagen treatment of endometriosis].
Seliger E; Kaltwasser P; Schneider F; Rothe K; Buchmann J
Ther Umsch; 1990 Dec; 47(12):945-50. PubMed ID: 2096479
[TBL] [Abstract][Full Text] [Related]
27. [Clinico-morphological changes during treatment of endometrial cancer with progestins].
Shuvaeva NI; Vekhova LI; Nikitina NI; Gosh TE; Nevskaia EA
Vopr Onkol; 1980; 26(6):22-7. PubMed ID: 7385724
[TBL] [Abstract][Full Text] [Related]
28. Progestogens in the treatment of carcinoma of the endometrium.
Kennedy BJ
Surg Gynecol Obstet; 1968 Jul; 127(1):103-14. PubMed ID: 5657772
[No Abstract] [Full Text] [Related]
29. [Results of high dosage progesterone therapy in carcinoma corporis uteri].
Seewald HJ; Böhm W; Przesang R
Zentralbl Gynakol; 1977; 99(7):392-5. PubMed ID: 868363
[TBL] [Abstract][Full Text] [Related]
30. [Gestagen treatment of endometrial carcinoma--theoretical and practical application].
Sugawa T; Sako H
Gan To Kagaku Ryoho; 1984 May; 11(5):1005-11. PubMed ID: 6721511
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass.
Victor A; Odlind V; Kral JG
Gastroenterol Clin North Am; 1987 Sep; 16(3):483-91. PubMed ID: 2449395
[TBL] [Abstract][Full Text] [Related]
32. Treatment and prognosis of endometrial cancer.
Whitfield CR
Clin Obstet Gynaecol; 1976 Aug; 3(2):407-23. PubMed ID: 1009728
[No Abstract] [Full Text] [Related]
33. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Okada H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
[TBL] [Abstract][Full Text] [Related]
34. [Hormonal contraceptives of differentiated composition -- effects on thrombocyte function (author's transl)].
Brandt M; Sommer J; Hofmann KD
Zentralbl Gynakol; 1981; 103(11):631-43. PubMed ID: 7269873
[TBL] [Abstract][Full Text] [Related]
35. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyprogesterone caproate therapy in advanced endometrial cancer.
Reifenstein EC
Cancer; 1971 Mar; 27(3):485-502. PubMed ID: 5549492
[No Abstract] [Full Text] [Related]
37. Use of progestational agents in the management of metastatic carcinoma of the endometrium.
Kistner RW; Griffiths CT
Clin Obstet Gynecol; 1968 Jun; 11(2):439-56. PubMed ID: 4879374
[No Abstract] [Full Text] [Related]
38. [Cytological check-up on the effectiveness of the hormonal treatment of endometriosis].
Kopecný J; Kopecná V
Cesk Gynekol; 1973; 38(1):38-9. PubMed ID: 4729366
[No Abstract] [Full Text] [Related]
39. [Use of synthetic progestins in diffuse fibrocystic mastopathy].
Manuilova IA; Pshenichnikova TIa; Zal'tsman IN; Borzakova LI
Sov Med; 1972 Dec; 35(12):30-4. PubMed ID: 4668331
[No Abstract] [Full Text] [Related]
40. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
Manuck TA
Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
